Bruton's tyrosine kinase (Btk), 3 a member of the Tec family of protein-tyrosine kinases, has been shown to play important roles in B cell development, activation, and survival. Mutations in Btk are known to lead to X-linked agammaglobulinemia in humans and X-linked immunodeficiency in mice (1). These diseases are characterized by a block in B-lymphopoiesis and CD5ϩ B-1 cell generation, defects in B cell receptor (BCR) signaling, and impairment in humoral immune responses to certain types of T cell-independent antigens (2). Structurally, Btk contains multiple protein-protein interaction domains. It has a pleckstrin homology domain for membrane localization following its activation, as well as Src homology 2, Src homology 3, and proline-rich domains for binding other signaling molecules. In addition, it possesses multiple tyrosine phosphorylation sites. Hence, Btk is postulated to play a key role in signal transduction processes.